Crossmark Global Holdings, Inc. Zoetis Inc. Transaction History

Crossmark Global Holdings, Inc.

$5.61 Billion
Q3 2024

A detailed history of Crossmark Global Holdings, Inc. transactions in Zoetis Inc. stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 32,688 shares of ZTS stock, worth $5.78 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

32,688

Previous 34,585 5.49%

Holding current value

$5.78 Million

Previous $6 Million 6.5%

% of portfolio

0.11%

Previous 0.11%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$172.58 - $196.48 $327,384 - $372,722	-1,897 Reduced 5.49%	32,688 $6.39 Million
Q2 2024 Jul 29, 2024	SELL	$145.54 - $178.83 $132,295 - $162,556	-909 Reduced 2.56%	34,585 $6 Million
Q1 2024 May 13, 2024	SELL	$165.67 - $199.94 $14,247 - $17,194	-86 Reduced 0.24%	35,494 $6.01 Million
Q4 2023 Feb 13, 2024	SELL	$151.44 - $200.09 $249,876 - $330,148	-1,650 Reduced 4.43%	35,580 $7.02 Million
Q3 2023 Nov 08, 2023	SELL	$167.14 - $192.77 $243,522 - $280,865	-1,457 Reduced 3.77%	37,230 $6.54 Million
Q2 2023 Jul 31, 2023	SELL	$160.94 - $186.23 $297,899 - $344,711	-1,851 Reduced 4.57%	38,687 $7.35 Million
Q1 2023 May 12, 2023	SELL	$145.48 - $175.02 $184,759 - $222,275	-1,270 Reduced 3.04%	40,538 $6.75 Million
Q4 2022 Jan 19, 2023	BUY	$131.14 - $157.47 $431,188 - $517,761	3,288 Added 8.54%	41,808 $6.13 Million
Q3 2022 Nov 01, 2022	SELL	$148.29 - $182.55 $239,191 - $294,453	-1,613 Reduced 4.02%	38,520 $5.71 Million
Q2 2022 Jul 29, 2022	SELL	$155.97 - $200.09 $925,993 - $1.19 Million	-5,937 Reduced 12.89%	40,133 $6.9 Million
Q1 2022 May 11, 2022	SELL	$181.39 - $234.03 $63,849 - $82,378	-352 Reduced 0.76%	46,070 $8.69 Million
Q4 2021 Jan 10, 2022	BUY	$193.69 - $247.03 $2.46 Million - $3.14 Million	12,691 Added 37.62%	46,422 $11.3 Million
Q3 2021 Oct 21, 2021	BUY	$189.29 - $209.69 $6.38 Million - $7.07 Million	33,731 New	33,731 $6.55 Million
Q3 2021 Oct 13, 2021	SELL	$189.29 - $209.69 $6.43 Million - $7.12 Million	-33,945 Closed	0 $0
Q2 2021 Jul 21, 2021	SELL	$155.9 - $187.99 $170,398 - $205,473	-1,093 Reduced 3.12%	33,945 $6.33 Million
Q1 2021 Apr 15, 2021	SELL	$144.0 - $169.39 $23,040 - $27,102	-160 Reduced 0.45%	35,038 $5.52 Million
Q4 2020 Jan 14, 2021	SELL	$157.07 - $174.35 $13,979 - $15,517	-89 Reduced 0.25%	35,198 $5.83 Million
Q3 2020 Oct 08, 2020	SELL	$137.1 - $165.37 $293,256 - $353,726	-2,139 Reduced 5.72%	35,287 $5.84 Million
Q2 2020 Aug 14, 2020	SELL	$111.92 - $142.53 $245,104 - $312,140	-2,190 Reduced 5.53%	37,426 $5.13 Million
Q1 2020 Apr 28, 2020	SELL	$92.66 - $144.94 $53,186 - $83,195	-574 Reduced 1.43%	39,616 $4.66 Million
Q4 2019 Feb 06, 2020	SELL	$116.25 - $133.25 $354,562 - $406,412	-3,050 Reduced 7.05%	40,190 $5.32 Million
Q3 2019 Oct 09, 2019	SELL	$112.57 - $128.43 $360,899 - $411,746	-3,206 Reduced 6.9%	43,240 $5.39 Million
Q2 2019 Jul 09, 2019	SELL	$97.98 - $114.28 $127,374 - $148,564	-1,300 Reduced 2.72%	46,446 $5.27 Million
Q1 2019 May 02, 2019	SELL	$81.56 - $100.67 $29,850 - $36,845	-366 Reduced 0.76%	47,746 $4.81 Million
Q4 2018 Jan 31, 2019	SELL	$79.28 - $95.27 $705,512 - $847,807	-8,899 Reduced 15.61%	48,112 $4.12 Million
Q3 2018 Nov 08, 2018	SELL	$83.5 - $93.23 $411,905 - $459,903	-4,933 Reduced 7.96%	57,011 $5.22 Million
Q2 2018 Jul 31, 2018	SELL	$79.9 - $89.2 $143,180 - $159,846	-1,792 Reduced 2.81%	61,944 $5.28 Million
Q1 2018 Apr 16, 2018	SELL	$71.51 - $84.69 $642,946 - $761,447	-8,991 Reduced 12.36%	63,736 $5.32 Million
Q4 2017 Feb 05, 2018	BUY	$63.24 - $72.8 $116,741 - $134,388	1,846 Added 2.6%	72,727 $5.24 Million
Q3 2016 Oct 25, 2017	BUY	N/A	70,881	70,881 $4.52 Million

Others Institutions Holding ZTS

# of Institutions

1,956

Shares Held

412M

Call Options Held

1.02M

Put Options Held

1.09M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.8B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.

Account

Crossmark Global Holdings, Inc. Zoetis Inc. Transaction History